Zhejiang Chimin Pharm Co Ltd (603222) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Zhejiang Chimin Pharm Co Ltd (603222) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥3.84 Million ≈ $562.44K USD) by net assets (CN¥1.49 Billion ≈ $217.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603222 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Zhejiang Chimin Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Zhejiang Chimin Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Chimin Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Chimin Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kindom Construction Corp TW:2520	0.059x
Fundamenta Real Estate AG SW:FREN	0.017x
Z Squared Inc. NASDAQ:ZSQR	-0.095x
COGNYTE SOFTWARE LTD F:81M	0.087x
Chongqing Shunbo Aluminum Co Ltd SHE:002996	-0.026x
Rosenbauer International AG VI:ROS	-0.110x
Jiangxi Chen Guang New Materials Co Ltd SHG:605399	-0.014x
Zhejiang Qianjiang Biochemical Co Ltd SHG:600796	0.057x

Annual Cash Flow Conversion Efficiency for Zhejiang Chimin Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Chimin Pharm Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Chimin Pharm Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.31 Billion ≈ $191.04 Million	CN¥-10.35 Million ≈ $-1.51 Million	-0.008x	-117.04%
2024-12-31	CN¥1.57 Billion ≈ $229.47 Million	CN¥72.99 Million ≈ $10.68 Million	0.047x	-44.90%
2023-12-31	CN¥1.66 Billion ≈ $242.89 Million	CN¥140.20 Million ≈ $20.52 Million	0.084x	-26.76%
2022-12-31	CN¥1.77 Billion ≈ $259.65 Million	CN¥204.65 Million ≈ $29.95 Million	0.115x	-45.24%
2021-12-31	CN¥1.37 Billion ≈ $201.14 Million	CN¥289.49 Million ≈ $42.36 Million	0.211x	+32.51%
2020-12-31	CN¥1.05 Billion ≈ $153.10 Million	CN¥166.29 Million ≈ $24.33 Million	0.159x	+11.61%
2019-12-31	CN¥1.07 Billion ≈ $156.99 Million	CN¥152.77 Million ≈ $22.36 Million	0.142x	+20.21%
2018-12-31	CN¥1.05 Billion ≈ $153.15 Million	CN¥123.99 Million ≈ $18.14 Million	0.118x	+65.39%
2017-12-31	CN¥928.28 Million ≈ $135.84 Million	CN¥66.49 Million ≈ $9.73 Million	0.072x	-19.65%
2016-12-31	CN¥808.94 Million ≈ $118.37 Million	CN¥72.12 Million ≈ $10.55 Million	0.089x	-23.45%
2015-12-31	CN¥750.99 Million ≈ $109.89 Million	CN¥87.46 Million ≈ $12.80 Million	0.116x	-33.52%
2014-12-31	CN¥441.55 Million ≈ $64.61 Million	CN¥77.36 Million ≈ $11.32 Million	0.175x	-20.95%
2013-12-31	CN¥488.13 Million ≈ $71.43 Million	CN¥108.19 Million ≈ $15.83 Million	0.222x	-43.57%
2012-12-31	CN¥432.53 Million ≈ $63.29 Million	CN¥169.88 Million ≈ $24.86 Million	0.393x	+357.29%
2011-12-31	CN¥383.04 Million ≈ $56.05 Million	CN¥32.90 Million ≈ $4.81 Million	0.086x	--

About Zhejiang Chimin Pharm Co Ltd

SHG:603222 China Medical Instruments & Supplies

Market Cap

$640.82 Million

CN¥4.38 Billion CNY

Market Cap Rank

#11189 Global

#3190 in China

Share Price

CN¥8.34

Change (1 day)

+3.09%

52-Week Range

CN¥6.62 - CN¥14.06

All Time High

CN¥57.73